ProMIS Neurosciences, Inc.
PMN
$0.5359
-$0.0131-2.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 21.10M | 13.98M | 10.64M | 8.54M | 7.12M |
| Gross Profit | -21.10M | -13.98M | -10.64M | -8.54M | -7.12M |
| SG&A Expenses | 3.48M | 3.13M | 2.69M | 6.16M | 5.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.58M | 17.11M | 13.33M | 14.70M | 12.78M |
| Operating Income | -24.58M | -17.11M | -13.33M | -14.70M | -12.78M |
| Income Before Tax | -8.43M | -934.00K | 2.78M | -563.40K | -12.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.43 | -0.93 | 2.78 | -0.56 | -12.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.43M | -934.00K | 2.78M | -563.40K | -12.20M |
| EBIT | -24.58M | -17.11M | -13.33M | -14.70M | -12.78M |
| EBITDA | -6.93M | -9.64M | -13.31M | -14.67M | -12.75M |
| EPS Basic | -0.20 | -0.04 | -0.02 | -0.19 | -0.69 |
| Normalized Basic EPS | -0.06 | 0.04 | 0.05 | -0.12 | -0.43 |
| EPS Diluted | -0.20 | -0.04 | -0.02 | -0.19 | -0.69 |
| Normalized Diluted EPS | -0.06 | 0.04 | 0.05 | -0.12 | -0.43 |
| Average Basic Shares Outstanding | 134.54M | 119.46M | 104.15M | 88.91M | 71.26M |
| Average Diluted Shares Outstanding | 134.59M | 119.51M | 104.19M | 88.96M | 71.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |